Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 1:28 pm Purchase |
2024-12-31 | 13G | IRadimed Corporation IRMD |
Nine Ten Capital Management | 905,926 7.100% |
106,560 (+13.33%) |
Filing History |
| 2024-11-14 3:35 pm Sale |
2024-09-30 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 1,000 0.000% |
-642,206 (-99.84%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | IRadimed Corporation IRMD |
BLACKROCK INC BLK |
939,737 7.400% |
0 (Unchanged) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | IRadimed Corporation IRMD |
BLACKROCK INC BLK |
939,737 7.400% |
939,737 (New Position) |
Filing History |
| 2024-02-13 4:25 pm Sale |
2023-12-31 | 13G | IRadimed Corporation IRMD |
Susi Roger E. | 4,587,950 36.400% |
-1,212,050 (-20.90%) |
Filing History |
| 2024-02-12 12:03 pm Purchase |
2023-12-31 | 13G | IRadimed Corporation IRMD |
Nine Ten Capital Management | 799,366 6.300% |
17,600 (+2.25%) |
Filing History |
| 2024-02-09 3:54 pm Purchase |
2023-12-31 | 13G | Baker Hughes Company BKR |
BLACKROCK INC BLK |
651,948 5.200% |
651,948 (New Position) |
Filing History |
| 2024-02-02 09:44 am Sale |
2023-12-31 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 643,206 5.100% |
-101,798 (-13.66%) |
Filing History |
| 2023-02-14 08:16 am Purchase |
2022-12-31 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 745,004 5.900% |
98,593 (+15.25%) |
Filing History |
| 2023-02-13 12:48 pm Sale |
2022-12-30 | 13G | IRadimed Corporation IRMD |
Renaissance Technologies LLC | 594,312 4.730% |
-99,000 (-14.28%) |
Filing History |
| 2023-02-10 10:22 am Purchase |
2022-12-31 | 13G | IRadimed Corporation IRMD |
Nine Ten Capital Management | 781,766 6.200% |
51,107 (+6.99%) |
Filing History |
| 2022-09-01 09:00 am Purchase |
2022-08-29 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 646,411 5.100% |
646,411 (New Position) |
Filing History |
| 2022-02-11 2:14 pm Sale |
2021-12-31 | 13G | IRadimed Corporation IRMD |
Renaissance Technologies LLC | 693,312 5.620% |
-44,845 (-6.08%) |
Filing History |
| 2022-02-09 2:26 pm Purchase |
2021-12-31 | 13G | IRadimed Corporation IRMD |
Nine Ten Capital Management | 730,659 5.900% |
65,899 (+9.91%) |
Filing History |
| 2021-02-12 11:17 am Purchase |
2020-12-31 | 13G | IRadimed Corporation IRMD |
Nine Ten Capital Management | 664,760 5.400% |
664,760 (New Position) |
Filing History |
| 2021-02-10 11:21 am Purchase |
2020-02-06 | 13G | IRadimed Corporation IRMD |
Renaissance Technologies LLC | 738,157 6.020% |
738,157 (New Position) |
Filing History |